Chelsea Therapeutics (CHTP) Slashed 20%+ on Trade Resumption
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) has resumed trading and is down 22 percent following an update on Northera.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SunOpta (STKL) to Acquire Sunrise Holdings in ~$450M Deal
- After five-week shut down, Greek stocks plummet
- 500.com Ltd. (WBAI) Ramps to Session Highs
Create E-mail Alert Related CategoriesFDA, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!